The Impacts of Inclusion in Clinical Trials on Outcomes among Patients with Metastatic Breast Cancer (MBC)
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference33 articles.
1. Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000;K Shibuya;BMC Cancer,2002
2. The global breast cancer burden: variations in epidemiology and survival;GN Hortobagyi;Clin Breast Cancer,2005
3. Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer;PA Greenberg;J Clin Oncol,1996
4. The role of chemotherapy for metastatic breast cancer;KD Miller;Hematol Oncol Clin North Am,1999
5. Docetaxel (Taxotere): an effective agent in the management of second-line breast cancer;AT van Oosterom;Semin Oncol,1995
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Enrollment of older metastatic breast cancer patients in first-line clinical trials: 9-year experience of the large-scale real-life multicenter French ESME cohort;Breast Cancer Research and Treatment;2022-01-05
2. PI3K/AKT Signaling in Breast Cancer Molecular Subtyping and Lymph Node Involvement;Disease Markers;2019-11-06
3. Global analysis of metastatic breast cancer policy gaps and advocacy efforts across the patient journey;The Breast;2018-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3